SWAP70 organizes the actin cytoskeleton and is essential for phagocytosis.
(c) GFP-tagged phosphoinositide probes (PI probe-GFP; green in merge) were co-expressed with non-targeting siRNA (siControl) or SWAP70 siRNA (siSWAP70) in zymosan-pulsed dendritic cells. The PI probes for PI(4,5)P 2 (PH-domain of PLCδ1 (PLCD1)), PI(3,4,5)P 3 (PH-domain of AKT) and PI(3,4)P 2 (PH-domain of TAPP2 (PLEKHA2)) were used. Left: representative confocal images (from 3-5 donors/condition). Arrowheads: PI probe-positive phagosomes. BF: bright field. Right: representative Western blots and quantifications of knockdown efficiencies (mean ± SEM). GAPDH: loading control. Scale bars: 2 µm (a, b), 10 µm (c).
Legends to Supplemental Movies
Movie S1; related to Figure 1 . Live cell imaging of SWAP70-GFP and LifeAct-RFP recruitment to the phagosome. Time-lapse epi-fluorescence imaging of dendritic cells transiently expressing SWAP70-GFP (green) and LifeAct-RFP (magenta) and pulsed with IgG-opsonized zymosan. Images were acquired every 20 sec. BF: bright field. Scale bar, 5 µm.
Movies S2-6; related to Figure 1 . Ultrastructure of SWAP70 on the phagosomal surface by multicolor 3D-STED microscopy. Dendritic cells were pulsed with zymosan (blue; autofluorescent core) and immunostained for SWAP70 (magenta). Total membranes were labeled with the fixable endocytic marker mCLING (green; Revelo, et al., 2014) . The bright mCLING-labeled structures surrounding the phagosome are endo/lysosomal compartments. The movies show 3D-rotations of single SWAP70-positive phagosomes. Note the alignment of SWAP70 in concentric fibers (movies 2-4) and rings (movies 5-6) on the surface of the phagosomes. The ventral membrane is positioned on the surface of the microscope cover glass; the dorsal membrane is facing away from it. Scale bars, approximately 2 µm. 
Supplemental Experimental Procedures Particle preparation and phagocytosis assays
IgG-coated latex beads were produced by incubating 0.3% streptavidin bead suspension with 1.3 mg ml -1 biotin-SP (long spacer) Chrompure human IgG (Jackson ImmunoResearch; 009-060-003) for 30 min at 37 o C followed by extensive washing. The beads were added at a 1:10 cell-to-beads ratio. IgG opsonized zymosan particles were produced by incubating 20 mg/ml zymosan suspension with an equal volume of Opsonizing solution from ThermoFisher (Z2850) for 60 min at 37 o C followed by extensive washing. FITC-labeled zymosan was purchased from ThermoFisher (Z2841). Unlabeled zymosan was from Sigma (Z4250-1G). The same zymosan was labeled with Alexa fluor 633 maleimide (Life Technologies) by incubating 16.4 mg ml -1 with 77 µM in 0.2 M Nacarbonate at pH 9.0 for 1 hour followed by vigorous washing. BSA Alexa fluor 488 conjugate was from ThermoFisher (cat. No. A13100). For the SHIP1 (INPP5D) or SHIP2 (INPPL1) inhibition, cells were incubated with zymosan at 1:10 cell-to-particles and either with 3AC (Echelon; B-0341; 10-200 µM in ethanol) or AS1949490 (Echelon; B-0342; 1.25-200 µM in DMSO).
Cell viability assay
For cell viability, 0.66 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Sigma M2128-1G) was applied to the cells together with 3AC or AS1949490 for 2 h. The MTT reaction was stopped with lysis buffer containing 90% isopropanol, 0.0125% SDS and 0.04 M HCl. Absorbance was measured at 595 nm to determine cell death.
SiRNA knock-down
Knockdown in human dendritic cells was performed as described (Dingjan et al., 2016) , except that 3 day differentiated monocytes were used for transfection and samples were used 24-72 h post-transfection. A mix of 3 siRNAs was used (Life Technologies): GCCUU CAGAC UCAAG UGGAA CUUCA, AAAGA AGCUG GAGAU GGCAA CUAAU, and CAGAA GAGAU UGAAU ACCUG CUUAA. Control samples were transfected with irrelevant ON-TARGET plus non-targeting (NT) siRNA (Dharmacon). For the rescue experiments and the combination of siRNA with phosphoinositide probes, day 6 differentiated monocytes were simultaneously transfected with siRNA and plasmid DNA and used 24 h post-transfection. For all experiments, only samples with knockdown levels above 70% (72 h post-transfection) or 40% (24 h) were used.
Immunofluorescence
For immunofluorescence, cells were incubated with zymosan at 1:10 cell-to-zymosan ratio in serum-free medium for 15 to 60 minutes. The cells were subsequently fixed with 4% PFA in PBS and permeabilized in S-PBA (0.1% Saponin, 0.5% BSA and 0.01% NaN 3 in PBS) for 5 min. Primary and secondary antibodies were incubated in S-PBA. Cells were embedded in DAPI containing mounting medium containing 0.01% (v/v) 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and 68% (v/v) glycerol in 200 mM sodium phosphate buffer at pH 7.5. In order to label the phagocytic cups, FITC-labeled zymosan was used and samples were labeled with an antibody directed against FITC prior to permeabilization.
PCR
The total mRNA from day 6 differentiated monocytes was isolated with the Quick-RNA MiniPrep kit (Zymo Research, R1055) and reversely transcribed into cDNA. SHIP1 (INPP5D) mRNA was amplified by PCR with 3 forward primers (nucleotides 128-147: GCGTG CTGTA TCGGA ATTGC; 354-372: AAGTG TCGTG TCTCC ACCC; 433-454: TTTTC AAACG AGAAT CCCCG AG) and 3 reverse primers (232-211: TGGTG AAGAA CCTCA TGGAG AC; 452-430: CGGGG ATTCT CGTTT GAAAA AGG; 579-559: GGCGA GCTGA GTGCT TAAAT A). SHIP2 (INPPL1) mRNA was amplified with one forward primer (198-217: GCACA CGTAT CGCAT TCTGC) and reverse primer (364-344: CTCGC TCACC CTCTA CAGGA A).
